Table 2.
Patient and clinical characteristics
| Variable | No. of cases (n = 103) |
|---|---|
| Age, mean ± SD (range of years) | 80.3 ± 3.9 (75–91) |
| Sex (%) | |
| Male | 33 (32.0) |
| Female | 70 (68.0) |
| ECOG PS, n (%) | |
| 0 | 3 (2.9) |
| 1 | 48 (46.6) |
| 2 | 36 (35.0) |
| 3 | 15 (14.6) |
| 4 | 1 (1.0) |
| Stage, n (%) | |
| I | 4 (3.9) |
| II | 5 (4.9) |
| III | 17 (16.5) |
| IV | 77 (74.8) |
| Cancer type, n (%) | |
| Hematological | 28 (27.2) |
| Mammary | 25 (24.3) |
| Gastrointestinal | 36 (35.0) |
| Othersa | 14 (13.6) |
| Serum albumin (g/dl) mean ± SD | 3.49 ± 0.52 |
| Specific organ disorder, n (%)b | |
| Yes | 29 (28.2) |
| No | 74 (71.8) |
| Past chemotherapy history, n (%) | |
| Yes | 43 (41.7) |
| No | 60 (58.3) |
SD standard derivation
aIncludes 9 pulmonary, and one each of oral, sarcoma, renal, gynecological, unknown origin, and double cancer
bCharlson comorbidity index (CCI) score of more than 2 points